When you grow old, your black hair slowly turned to slivery white, and youth started to slip away from you as it never existed. Being old is always a fearful progress in your life journey. This is perfectly normal, because there are still people who love you and who you love, they are always in your heart. But one day when you wake up, figures casually appears in front of your eyes. You could only gaze and stare into the blankness, trying to sort things out right. At last all you managed to say is: “Who are you?”. Alzheimer’s disease, also called AD, is an irreversible, progressive brain disorder that slowly destroys memory, thinking skills, and the ability to carry out the simplest tasks. AD is named after Dr. Alois Alzheimer, who found this disease. (NIH 2017 May 16th) Alzheimer’s Disease is a serious issue that must be researched in China, because it’s getting more and more common, and this disease still has no cure. Some people say AD will not affect China in future, because it’s effect is not yet seen from the surface.
Currently, Alzheimer’s Disease is getting more common in China and the disease population is still raptly increasing. “The prevalence of AD in China has been found between 0.7% to 6.6% in individuals, meaning in a thousand people there could be 7~66 patient.” (Li 2018 Nov) This is very high. “Out of a survey of 130 people from variety ages, 30% claimed they know someone/has a family member of AD.” (Zhou 2019 May) Research strongly suggests larger percentage population in world will suffer from this disease, and it’s unstoppable. There’s more cases of Alzheimer’s in China than any other country (Alzheimer research UK 2013 June 6th), so AD became a common problem among Chinese population older than 65 years. This disease would also cause variety of issues and economic problems in future. In USA it’s already estimated $100 billion for the cost of AD in total. (Xiao) With AD patient around, families will need to bear more suffer. Police station will need to take care more cases of AD patients getting lost. China will definitely face this challenge economically and socially in future as AD patient continue increases as AD’s popularity increases.
In addition, Alzheimer’s Disease still has no cure since founded. US only approved 2 types of medications: Namenda and N-methyl Dasparate (NIH 2018 April 1st) out to use, and medication can only temporarily reduce the symptoms. Family support could help, but overall it doesn’t work very well. (NHS 2018 Oct 5th) China does not provide free medical insurance for AD, meaning you have to pay this disease for yourself, unlike some other diseases that are given somewhat subsidize. Going through AD is a long process with heavy costs, which means some families can’t afford, they might give up on the patient/don’t provide medical treatment (which patient gets worse quicker). There’s 0% chance surviving rate with AD, (Alzheimer Association 2019) but patient’s remaining life time is not low, usually in an average of 4.1 years. (Helzner 2008 Nov 4) Patients die slowly because the loss of their sense and minds, also with complications. This is a long time while patient needs get through and be cared, and elderlies’ life quality will definitely recede from view. On so many internal/ local websites, reports of “Alzheimer cure is already founded” are all over the place, trying to make us believe, benumb our minds, trying to give us unrealistic hopes. But the fact is, since 1906 when Alzheimer has been found, until 2019, throughout this 113 years of history, there is still no cure. There are ways to prevent Alzheimer, but there is absolute no cure yet. Few medicines could have a chance that might work, but there’s still no official effective method, or in another words: the actual cure.
Some people say AD will not affect China in future, which this is not an issue we should be worried about. But in fact, there’s absolutely ZERO reliable information about AD impact on China government websites anywhere. (Zhou 2019 May) People know less, of course people care less, think less. China’s research among AD is very unnoticeable. AD is already the third costliest disease in US after cancer and heart disease. And this is the data from 1998. “The annual costs of AD were already estimated from 80-100 billion in US, which includes direct, indirect and intangible costs.” (Zhu 2006 Jun) USA is already under the economic threat of AD, US medication association from government previously announced they are under pressure of providing free care for AD patients. On the other hand, China announced NO reliable research/statistics about AD impact, all the costs estimated are variably different. It’s very clear that the cost of AD in China is not less than US because of China’s large population groups, and AD will definitely affect China’s future economy wise, social wise, and it will only push threat on elderlies’ heath.
In conclusion, Alzheimer’s Disease is a serious issue that must be researched in China. If not, more and more elderlies will suffer from this disease, along with their families. The life expectancy and living quality for old people will only decrease, the research also indicates a huge economic impact is coming on the way. Clearly, what China is doing is not enough. No reliable articles are found if citizens want to research about AD. China contributed not so many useful progress. If you want to live healthy for the rest of your life; if you don’t want to worry about your parent’s health when you are still struggling with your job/work; if you don’t want to experience extreme mental pressure: More of Alzheimer’s Disease research needs start in China now, right in this moment.
“How Is Alzheimer’s Disease Treated?” NIH, 1 Apr. 2018, www.nia.nih.gov/health/
“Inside the Brain- a Tour of How the Mind Works.” Alzheimer’s Association, 2018,
Li, Kanglan, et al. “The Prevalence of Alzheimer’s Disease in China: A
Systematic Review and Meta-analysis.” NCBI, Nov. 2018, www.ncbi.nlm.nih.gov/
“Treatment – Alzheimer’s Disease Contents.” NHS, 5 Oct. 2018, www.nhs.uk/
“More Cases of Alzheimer’s in China than Any Other Country.” Alzheimer’s
Research UK, www.alzheimersresearchuk.org/
Zhu, Carolyn W., and Mary Sano. “Economic Considerations in the Management of
Alzheimer’s Disease.” NCBI, June 2006, www.ncbi.nlm.nih.gov/pmc/articles/
Helzner, E. P. “Survival in Alzheimer Disease.” NCBI, 4 Nov. 2008,
Zhou, Jasmine. “Alzheimer’s Disease Survey Form.” Microsoft Forms, May 2019,